Skip to content

4Accepted Sep 14, 5:53 PM ET

Diversified Healthcare (DHC) CEO Christopher J. Bilotto Receives 59,681-Share Award

NASDAQ:DHCDIVERSIFIED HEALTHCARE TRUST

Accepted (ET)

5:53 PM

Sep 14, 2026

Filed

Sep 14, 2026

Documents

1

Size

5.5 KB

Summary

Diversified Healthcare (DHC) CEO Christopher J. Bilotto Receives 59,681-Share Award

Updated

What Happened
Christopher J. Bilotto, President & CEO and a director of Diversified Healthcare Trust (NASDAQ: DHC), was awarded 59,681 shares on 2026-09-10 pursuant to the issuer's equity compensation plan. The award is reported as an acquisition (transaction code A); no per-share price is listed on the Form 4 (value would equal the market price on the grant date).

Key Details

  • Transaction date: 2026-09-10 (reported on Form 4 filed 2026-09-14). Filing appears timely (within the required 2 business days).
  • Transaction type/code: Award/Grant (A) — equity compensation plan award.
  • Shares awarded: 59,681 shares. Price: N/A (no purchase price reported).
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes: (1) Award pursuant to the issuer’s equity compensation plan. (2) Mr. Bilotto discontinued participation in the company’s dividend reinvestment plan; 256.99 shares previously acquired via DRIP are now held directly, and 0.475 fractional shares were sold for cash.

Context: Equity awards to executives are a common form of compensation and are typically subject to vesting and plan terms (the filing notes only that this is an award under the company plan). This transaction is an acquisition of shares via compensation rather than an open-market purchase; it should be interpreted as compensation-related rather than a direct open-market bullish signal.

AI-written summary · check the filing